Found "Public health policy": 1,139 results
Sort by
Sort by
Relevance
India to establish Medical Technology Assessment Board
Rhythma Kaul / Hindustand TimesNew Delhi: India announced the setting up of a Medical Technology Assessment Board (MTAB) that will be one-stop shop to review standards for medicines, vaccines, devices and insurance.The Board’s recommendations will be the last word for health policies and healthcare
HITAP Foundation at PMAC 2025: Advancing AI-Driven Solutions for a Healthier World
January 29, 2025 – The Health Intervention and Technology Assessment Program (HITAP) Foundation participated in the Prince Mahidol Award Conference (PMAC) 2025, held from January 28 to February 2, 2025, in Bangkok, Thailand. This global event brought together health experts and leaders from the publ
General health check-ups ‘offer no benefit’
From Health news. BBC (http://www.bbc.co.uk/news/health-19964600)Visiting a doctor for a general check-up is unlikely to lead to a condition needing treatment being identified, but may cause undue stress, say experts.The Danish researchers that carried out the latest review, which involved more than
Landscape Analysis of HTA capacity in the ASEAN
The Association of Southeast Asian Nations (ASEAN) region is characterised by diversity. Progress towards Universal Health Coverage (UHC) and institutionalisation of priority setting through Health Technology Assessment (HTA) is varied and is dependent on several country-specific factors such as the proportion of public investment in health, politi
An empirical study looking at the potential impact of increasing cost-effectiveness threshold on reimbursement decisions in Thailand
Highlights
Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
How can we make better health decisions: a Best Buy for all?
Abstract
The World Health Organization (WHO) resolution calling on Member States to work towards achieving universal health coverage (UHC) requires them to prioritize health spending. Prioritizing is even more important as low- and middle-income countries transition from external aid. Countries w
Gates Foundation calls for more principled cost-effectiveness in health
This is a post by Amanda Glassman reproduced with permission from the Center for Global DevelopmentCost-effectiveness studies compare the costs and benefits of different interventions with the aim of improving decisions on the allocation of scarce resources for health. Or, put simply, they allow po
Evaluation the development of healthy public policies under the National Health Commission between 2007 and 2011
นโยบายสาธารณะเพื่อสุขภาพ (Healthy Public Policy) เป็นแนวคิดที่ได้รับการพัฒนามาเป็นระยะเวลายาวนาน นับตั้งแต่การกำหนดเป้าหมายการพัฒนาสุข
10 / Page